Cart
sales@molnova.com
SAMT-247
CAS No. 850715-59-2
SAMT-247( SAMT247 )
Catalog No. M16179 CAS No. 850715-59-2
SAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSAMT-247
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells.
-
DescriptionSAMT-247 potent HIV-1 nucleocapsid protein NCp7 inhibitor with EC50 of 0.6 uM with low cellular toxicity (TC50>100 uM) in cultured and primary cells; promotes covalent acetylation of Gag intracellularly, thereby blocking Gag processing and reducing infectivity.
-
In Vitro——
-
In Vivo——
-
SynonymsSAMT247
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number850715-59-2
-
Formula Weight266.32
-
Molecular FormulaC12H14N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N)CCNC(C1=CC=CC=C1C(C)=O)=S
-
Chemical NameEthanethioic acid,S-[2-[[(3-amino-3-oxopropyl)amino]carbonyl]phenyl] ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Miller Jenkins LM, et al. Nat Chem Biol. 2010 Dec;6(12):887-9.
molnova catalog
related products
-
HIV-1 Rev 34-50
HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. HIV-1 Rev peptide is a one of the cell-penetrating peptides (CPPs) derived from HIV-1 Rev protein residue 34-50. It is a RNA binding peptideand has been used to deliver macromolecules into cells.
-
Etravirine
A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.
-
Ibalizumab
Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.
